Delivery Order SPE2DB22D3301-SPE2DB25FX4PP
Award Date
10/29/24
Potential Completion Date
11/20/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.75 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, to support DLA's medical supply programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is a delivery order for the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine product. The contract is a firm fixed-price arrangement with a performance period extending through May 7, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The contract is a $1,850.16 firm-fixed-price delivery order with a period of performance through September 24, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a Firm Fixed Price Delivery Order contract worth $7,427.20 for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. This contract has a completion date of July 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. The order, valued at $1,856.75, has a completion date of March 4, 2024 and was awarded on February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to various U.S....
This is a delivery order under contract SPE2DB22D1106 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,635.40 firm fixed-price contract is for the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML medical product. The contract has an ultimate completion date of March 17, 2025. This delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, identified as SPE2DB22D3401|SPE2DB24FT3DU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $18,567.60 Firm Fixed Price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans...
This federal contract award is for the delivery of TICOVAC 1.2 MCG/0.25 ML SYRING 0.25ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,810.00, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,927.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of the vaccine TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. This contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $2,007.78 firm fixed price delivery order is for the supply of 4,564,884,032 units of the TENIVAC SYRINGE 0.5ML product. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...